Aptorum Group Limited (NASDAQ:APM) Short Interest Update

Aptorum Group Limited (NASDAQ:APM) was the recipient of a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 184,800 shares, an increase of 1,564.9% from the December 15th total of 11,100 shares. Currently, 4.7% of the shares of the stock are sold short. Based on an average trading volume of 2,190,000 shares, the short-interest ratio is presently 0.1 days.

Aptorum Group Stock Performance

Shares of NASDAQ APM traded down $0.08 during mid-day trading on Monday, reaching $1.31. The company had a trading volume of 114,837 shares, compared to its average volume of 2,597,329. The company has a 50-day moving average price of $1.07 and a two-hundred day moving average price of $2.18. Aptorum Group has a 1-year low of $0.46 and a 1-year high of $17.49.

About Aptorum Group

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.